ArticleScientific reports2026

A potential of serum anti-C1P IgG antibodies as biomarkers in differential diagnosis of relapsing-remitting multiple sclerosis.

Justyna Chojdak-Lukasiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.